Discure Technologies
Reversing Degenerative Disc Disease
Startup A Health Tech & Life Sciences Est. 2021
Total Raised
$21M
A
Last Round
$11M
3 rounds
Investors
7
7 public
Team
5
11-50 employees
Confidence
98/100
News
1
articles
Patents
1
About
Discure Technologies developed a minimally invasive device to treat and reverse degenerative disc disease, reducing pain and restoring functionality to the patient. The system is designed to eliminate the need for invasive surgery and reduce the use of opioids.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcarePatientsProviders
Business Model
B2C
Tags
medical-technologiesmedical-deviceshealthcareminimally-invasivedegenerative-diseases
Funding & Events
Sep 2024
SAFE $5M
Sanara Capital, Bold Capital Partners, Supernova Invest
Sep 2024
A Round $11M
Bold Capital Partners (Lead), Supernova Invest, Sanara Capital
Mar 2022
Seed $5M
Rainbow Medical (Lead), Johnson & Johnson Innovation, Katao Venture Partners, KYTO
News (1)
Sep 10, 2024 · www.calcalistech.com
growth-positive
Discure Technologies raises $16 million for degenerative disc disease treatment | CTech
InvestmentPartnersExpand
Details
Product Stage
R&D
Employees
11-50
Exact Count
11
District
Center District
Founded
2021
Registrar
516554326
Locations
Medinat HaYehudim Street 85, Herzliya, Israel
Links
Website
LinkedIn
Admin
Last Update
Nov 5, 2024
Claimed
Yes
Missing
markets
Team (5)
Hassan Serhan
Chairman
Yuval Mandelbaum
CEO
Yossi Gross
Founder
Founder
Shirley Giorini
CRO
Yehuda Zadok
CTO
Internal
Created by
Yuval Mandelbaum (yuvalrainbow@gmail.com)
Created
2020-12-17T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)